baber/WOPTO huggingface dataset:
Patent CS-205043-B2 (CS)
Title: Catalyser for the vapour reforming of the hydrocarbon
Inventor: BANKS REGINALD G S
IPC: C10G11/20
Filed: 1976-09-29
Abstract: 1525017 Steam reforming catalysts BRITISH GAS CORP 19 July 1976 [29 Sept 1975] 39724/75 Heading B1E [Also in Division C5] Catalysts comprise calcined, coprecipitated nickel and alumina, the nickel content of the unreduced, calcined catalyst being 50-65%, the sodium content is 0-0.1%, the potassium content is 0-0.43% and the total amount of sodium and potassium does not exceed 0.011 g-atoms/100g of catalyst, the water loss being not more than 11.2 when the combined sodium and potassium content is not greater than 0.05 wt. %. The water loss being defined as the percentage loss of weight, based on the original weight, of the catalyst precursor between 150 and 270‹C when heated at a rate of 15‹C/min in a dry stream of inert gas at ambient pressure.
Patent CS-197350-B2 (CS)
Title: Braking circuit for the vehicle wheel
Inventor: SUTTON CHRISTOPHER J
IPC: B60T8/60
Filed: 1972-10-19
Abstract: A braking system for a vehicle has an arrangement for releasing the vehicle brakes automatically in order to prevent skidding. When the vehicle is travelling over a rough surface, such as a cobbled road, the rotational deceleration of the wheel can result in releasing of the brakes without wheel skid, and delay means is provided for preventing this possibility.
Patent JP-3574200-B2 (JP)
IPC: B23K9/20
Filed: 1995-01-10
Granted: 2004-10-06
Abstract: For arc-welding studs of substantially annular crosssection, a stud holder 1 is surrounded by an electromagnet coil 5, the magnetic field of which is applied to the welding gap through a magnetic flux guiding portion 6, 7 so as to generate a magnetic field component extending radially of the stud 4 within the gap. This radial field component exerts a circumferential force on the arc to move it along the annular face of the hollow stud 4 thereby securely welding the stud 4 to the workpiece 2 along its entire annular cross-section. In order to minimise coupling of the magnetic field into the conductive workpiece 2, the flux guiding portion has a frusto-conical magnetic field former 7, the generatrix of which points to the welding zone 8, with the pole surface 9 formed at the tip of the field former 7 closely surrounding the welding gap.
Patent AU-682737-B2 (AU)
Title: Bicyclic carboxylic acid leukotriene B4 antagonists
Inventor: COHEN NOAL
IPC: A61K31/35
Filed: 1994-11-26
Granted: 1997-10-16
Abstract: The invention relates to compounds selected from the group consisting of the formulas:    <IMAGE>  Aas described herein. These compounds are potent leukotriene B4 antagonists and are therefore useful in the treatment of inflammatory diseases.
Patent AU-657514-B2 (AU)
Title: Method for production of solid pharmaceutical preparation
Inventor: MOLLOY THOMAS PATRICK
IPC: A61K9/00
Filed: 1992-01-03
Granted: 1995-03-16
Abstract: The invention provides a method for the production of a solid pharmaceutical preparation characterised by mixing together finely divided particles or granules of a medicament, or granules containing a medicament and excipients, and appropriate amounts of a finely divided amorphous or substantially amorphous coating polymer and plasticizer which dissolves the polymer, compressing the mixture into tablets, and heating the tablets to a temperature at which fusion of the polymer particles occurs; and a method for the production of a solid pharmaceutical preparation characterised in that a solid core is coated with a film coat by mixing or granulating finely divided particles of a membrane-forming amorphous or substantially amorphous polymer with a plasticizer which dissolves the polymer, encasing said solid core with the polymer mix, and heating the polymer-encased material to a temperature at which the amorphous or substantially amorphous polymer forms a continuous film.
Patent AU-668085-B2 (AU)
Title: Methods and apparatus for improved luminescence assays
Inventor: LELAND JOHN K
IPC: C12Q1/68
Filed: 1992-02-05
Granted: 1996-04-26
Abstract: The invention relates to an apparatus for performing a binding assay for an analyte of interest in a sample based upon measurement of electro-chemiluminescence at an electrode surface comprising an electrochemical cell having a sample-holding volume, inlet and outlet means; a working electrode system to provide electrochemical energy to trigger electrochemiluminescence; a voltage control device to supply voltage signals to the working electrode system; a magnet placed in proper orientation and in close proximity to the working electrode so that magnetically responsive particles will concentrate on the surface of the working electrode; a light detection/measurement device for measuring electrochemiluminescence triggered at the electrode surface; and a pump to provide for fluid transport to, through and from the electrochemical cell. The apparatus may be used in an electrochemiluminescence assay for an analyte of interest in which magnetically responsive particles are magnetically collected on the electrode surface and emitted electrochemiluminescence is measured using the light detector. <IMAGE>
Patent AU-707571-B2 (AU)
Title: Composition containing nucleic acids, preparation and uses
Inventor: BEHR JEAN-PAUL
IPC: A61P37/04
Filed: 1995-01-09
Granted: 1999-07-15
Abstract: The present invention relates to compositions comprising at least one nucleic acid and one lipopolyamine, and their utilisation in gene therapy, particularly for the transfert in vivo of nucleic acids.
Patent AU-611896-B2 (AU)
Title: Process for the elimination of radioactivity from effluents
Inventor: CAILLY FRANCINET
IPC: G21F9/12
Filed: 1988-04-26
Granted: 1991-06-27
Abstract: Radioactivity, and especially radium, is removed from an aqueous solution by a process characterised in that the solution is placed in contact with an organic phase containing at least one extractant chosen particularly from the group of fluorinated  beta -diketones. After phase separation, a radium-charged organic phase and a purified aqueous phase are recovered.
Patent AU-735081-B2 (AU)
Title: A-33 related antigens and their pharmacological uses
Inventor: ASHKENAZI AVI
IPC: A61P7/04
Filed: 1998-11-20
Granted: 2001-06-28
Abstract: A33 related antigens PRO301, PRO362 and PRO245, are new. Independent claims are also included for the following: (1) a nucleic acid comprising DNA having at least 95% sequence identity to: (a) a DNA molecule encoding PRO301 comprising amino acids 28-235 of a 299 amino acid sequence (given in the specification); (b) a DNA molecule encoding the same mature polypeptide encoded by cDNA in ATCC 209432 (designated DNA40628-1216); or (c) the complement of DNA in (a); (2) a nucleic acid comprising DNA having at least 80% sequence identity to: (a) a DNA molecule encoding PRO362 comprising amino acids 1-321 or 1-X (X = any of residues 271-280) of a 321 amino acid sequence (given in the specification); (b) a DNA molecule encoding the same mature polypeptide encoded by cDNA in ATCC 209620 (designated DNA45416-1251); or (c) the complement of DNA in (a); (3) production of PRO301, PRO362 or PRO245; isolated PRO301 comprising residues 28-235 of the 299 residue sequence; (4) isolated PRO362 comprising residues 1-229 or 1-X (X = 271-280) of the 321 residue sequence; (5) an isolated antibody which binds PRO301 or PRO362; (6) treating an inflammatory disease by administering a therapeutically effective amount of a PRO301, PRO362 or PRO245 antagonist or fragment; determining the presence of PRO301, PRO362 or PRO245; and (7) diagnosis of an inflammatory disease or tumor, by detecting the level of PRO301, PRO362 or PRO245 gene expression. ACTIVITY : Cytostatic; Anti-inflammatory. MECHANISM OF ACTION : Antagonist.
Patent AU-774286-B2 (AU)
Title: Adhesion promoters for monomer-free reactive polyurethanes
Inventor: KREBS MICHAEL
IPC: C09K3/10
Filed: 2000-11-25
Granted: 2004-06-24
Abstract: Polyurethane compositions are produced in a two-stage method. In a first step, a diol component with a molecular weight of less than 2000 is reacted with a monomeric diisocyanate with a molecular weight of less than 500 and the unreacted monomeric diisocyanate is removed from this reaction product. In a second step, the resulting high-molecular diisocyanate is reacted with a polyol to produce a reactive prepolymer with isocyanate and groups. The addition of polyisocyanates which are capable of migration and which have a substantially lower vapor pressure than diphenylmethanediisocyanate, improves the addition behavior of the invention polyurethane compositions. Reactive polyurethane compositions of this type are suitable for using as binding agents for reactive one or two component adhesives/sealants, which may optionally contain solvents. These compositions are also suitable for producing reactive hot melt adhesives when suitable polyols are selected. A substantial advantage of these compositions compared to known polyurethane compositions is the considerably lower proportion of monomeric diisocyanates with a molecular weight of less than 500.
Patent AU-697927-B2 (AU)
Title: Improvements in and relating to containers of particulate material
Inventor: EASON STEPHEN WILLIAM
IPC: A61J7/00
Filed: 1995-05-16
Granted: 1998-10-22
Abstract: A method of producing a container (201, 231, 350) having a plurality of apertures (eg 202, 232, 352) each containing a respective dose of powdered material, such as a medicament, involves placing an empty container in a position in which its apertures communicate with a reservoir (216, 84) of powdered material. The material is then passed, for example by the flow of gas, from the reservoir into the apertures to fill the latter, and the container is then separated from the reservoir and the apertures are optionally sealed with sheet material (204, 206, 321, 323). Since the apertures are filled, their volume determines the amount of each dose which therefore does not have to be measured prior to introduction into the apertures. The container may comprise a rigid or flexible plate and in latter case can be subsequently rolled into the form of a cylinder for use in an inhaler. Apparatus for performing the method, and an inhaler for use with a cylindrical container, are also shown.
Patent AU-706763-B2 (AU)
Title: Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
Inventor: WARD ERIC RUSSELL
IPC: C12Q1/68
Filed: 1995-06-08
Granted: 1999-06-24
Abstract: The present invention provides novel eukaryotic DNA sequences coding for native protoporphyrinogen oxidase (protox) or modified forms of the enzyme which are herbicide tolerant. Plants having altered protox activity which confers tolerance to herbicides and a method of selecting transformed plants are also provided.
Patent AU-703812-B2 (AU)
Title: Auxiliaries for paper finishing
Inventor: REINERS JURGEN
IPC: C08F220/10
Filed: 1995-05-05
Granted: 1999-04-01
Abstract: PCT No. PCT/EP95/01702 Sec. 371 Date Nov. 5, 1996 Sec. 102(e) Date Nov. 5, 1996 PCT Filed May 5, 1995 PCT Pub. No. WO95/31492 PCT Pub. Date Nov. 23, 1995This invention relates to compositions comprising a polyisocyanate having ionic groups or polyether groups and at least one member selected from the group consisting of a naturally occurring polymer, a polysiloxane graft copolymer, a water-dilutable synthetic polymer and a cationic polymer or a naturally occurring polymer and at least one member selected from the group consisting of a polysiloxane graft copolymer, a water-dilutable synthetic polymer and a cationic polymer.
Patent AU-615496-B2 (AU)
Title: A process for coating a tablet composition
Inventor: ALDERMAN DANIEL A
IPC: B32B7/02
Filed: 1988-11-25
Granted: 1991-10-03
Abstract: Tablets are coated with a solution obtained by dissolving in cold water granules obtained by comminuting an extruded mixture of plasticizer and thermally moldable polymer and, optionally, a pigment and/or surfactant. Preferably, the plasticizer is propylene glycol, polyethylene glycol or water and the polymer is hydroxypropyl methylcellulose, hydroxypropyl cellulose, carboxymethylcellulose or hydroxethyl cellulose.
Patent AU-708109-B2 (AU)
Title: Combustion burner and combustion apparatus provided with said burner
Inventor: KIYAMA KENJI
IPC: F23D1/00
Filed: 1997-04-30
Granted: 1999-07-29
Abstract: A combustion burner includes a mixture nozzle, a gas supply nozzle, and guide means. The mixture nozzle extends toward an interior of a furnace, and defines a mixture passage through which a mixture containing powdered solid fuel and gas for transferring the solid fuel flows. A distal end portion of the mixture nozzle is flared so that a flow passage area of the mixture passage increases progressively in a direction of flow of the mixture. The gas supply nozzle radially surrounds the mixture nozzle to define between the gas supply nozzle and the mixture nozzle a gas passage through which a combustion oxygen-containing gas flows toward the furnace. The guide means is provided within the mixture nozzle at a position upstream of the flared portion of the mixture nozzle with respect to a flow of the mixture so as to make the mixture flow straightly along an inner peripheral surface of the flared portion of the mixture nozzle. <IMAGE>
Patent AU-664862-B2 (AU)
Title: Process for establishing optimum soil conditions by naturally forming tilth
Inventor: KURNER RUDOLF
IPC: C05D1/04
Filed: 1992-10-13
Granted: 1995-12-07
Abstract: PCT No. PCT/EP92/02356 Sec. 371 Date Nov. 15, 1994 Sec. 102(e) Date Nov. 15, 1994 PCT Filed Oct. 13, 1992 PCT Pub. No. WO93/08143 PCT Pub. Date Apr. 29, 1993A process is disclosed for establishing optimum soil conditions by biologically disintegrating minerals in the presence of Ca compunds, clay and protein- and lignocellulose-containing organic vegetable waste, as well as protein-containing organic animal waste. The process includes the following steps: a) finely crushing a mixture of minerals containing at least potassium, magnesium, phosphate and silicate, all in insoluble form; b) subjecting the vegetable and animal organic waste to an usual preliminary crushing step; c) micronizing the organic waste, preferably while homogeneously mixing it with the mixture of minerals; and d) fermenting the mixture of micronized organic waste and finely crushed minerals in the presence of finely crushed Ca-compound and clay, in microbially appropriate conditions.
Patent AU-617736-B2 (AU)
Title: Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
Inventor: CARINI DAVID JOHN
IPC: C07D233/64
Filed: 1989-01-06
Granted: 1991-12-05
Abstract: The invention encompasses a pharmaceutical composition comprising a diuretic or a non-steroidal antiinflammatory drug, a pharmaceutical suitable carrier and an antihypertensive and processes for production of these compositions.
Patent AU-567748-B2 (AU)
Title: Phosphate coatings on metals
Inventor: PORTZ HEINZ
IPC: C23C22/42
Filed: 1984-07-18
Granted: 1987-12-03
Abstract: Phosphate conversion coating accelerators consisting essentially of amidosulfonic acid, N-substitution products and salts thereof, sulfonamides, 1,2,3-oxathiazin-4(3H)-one salts or 6-alkyl derivatives thereof, and ortho-aniline sulfonic acid or its derivatives aklyl-substituted on the ring and salts thereof, and mixtures of the foregoing, and a process for their use.
Patent AU-713062-B2 (AU)
Title: Biconvex rapidly disintegrating dosage forms
Inventor: LAWRENCE JANICE
IPC: A61K31/445
Filed: 1997-06-10
Granted: 1999-11-25
Abstract: Preparation of solid rapidly disintegrating dosage form (SDF) comprising a porous network of matrix forming materials (MFM) comprises: (a) overfilling a mould with a predetermined amount of aqueous composition comprising MFM so that a convex meniscus is created on top of the mould; (b) freezing; and (c) removing the solvent by subjecting the product to lyophilisation or to solid state dissolution leaving a porous network of MFM. The shape of the bottom surface of the mould is a mirror image of the shape of the frozen meniscus on the top, the mirror plane being parallel to the plane defined by the rim of the mould, yielding a dosage form shaped as a biconvex tablet, having symmetrical top and bottom surfaces. The SDF prepared as above is claimed per se. Also claimed is a metal or plastic sheet for use in the above process for preparing dosage forms shaped as biconvex tablets having symmetrical top and bottom surfaces comprising moulds arranged in a regular pattern, the shape of the bottom surface of each mould being a mirror image of the shape of a predetermined convex meniscus on the top, the mirror plane being parallel to the plane defined by the rim of the mould.
Patent AU-613167-B2 (AU)
Title: Compressing anastomosis coupling assembly
Inventor: TEODORESCU IONEL E
IPC: A61B17/11
Filed: 1989-03-28
Granted: 1991-07-25
Abstract: A compression anastomosis assembly (10) of, interlocking coupling members (12, 22, 32), particularly suitable for use in achieving anastomosis of tubular organs, having an improved locking feature to prevent inadvertent disassembly of installed coupled members. The design and configuration of the members also provide for ease in placement of the assembly in a living body wherein preferably one assembly member includes a cutting guide (46, 56) and a cutting ring (62) which facilitate use of a cutting implement (86) commonly associated with a device suitable for use during assembly implantation.
Patent AU-670064-B2 (AU)
Title: Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
Inventor: GLUCHOWSKI CHARLES
IPC: C07D403/12
Filed: 1993-01-12
Granted: 1996-07-04
Abstract: A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having the formula:   <IMAGE>   ,pharmaceutically acceptable acid addition salts thereof and mixtures thereof, wherein R1 and R4 are independently selected from the group consisting of H and alkyl radicals having 1 to 4 carbon atoms; the R2s are independently selected from H or alkyl radicals having 1 to 4 carbon atoms or are, together, oxo; the R3s are independently selected from H or alkyl radicals having 1 to 4 carbon atoms or are, together, oxo; the 2-imidazolin-2-ylamino group may be in any of the 5-, 6, 7- or 8- positions of the quinoxaline nucleus; and R5, R6 and R7 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals having 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as reduction in peripheral pain, anesthetization of the central nervous system, constriction of one or more blood vessels, reduction in or prevention of at least one effect of ischemia, decongestion of one or more nasal passages, and reduction of at least one effect of an inflammatory disorder.
Patent AU-697250-B2 (AU)
Title: A feeding device, in particular for pigs
Inventor: KASPERSEN PETER
IPC: A01K5/02
Filed: 1995-11-28
Granted: 1998-10-01
Abstract: PCT No. PCT/DK95/00479 Sec. 371 Date May 28, 1997 Sec. 102(e) Date May 28, 1997 PCT Filed Nov. 28, 1995 PCT Pub. No. WO96/16537 PCT Pub. Date Jun. 6, 1996A feeding device, in particular for pigs, of the kind comprising a feed container (10) with a tubular outlet and preferably connected to a tubular transporter, by means of which the feed is brought to the feeding device, and where the pigs may act on the lower part of the tube (10) with their snouts for delivery of the feed into a trough (4). The feeding device is particular in that the lower part of the tube (10) is shaped as a separate deflectably suspended part and where there is provided between this and the lower edge of the fixed part of the tube a portioning device, through which the feed is supplied when the deflectable part is deflected.
Patent AU-570105-B2 (AU)
Title: Pressure swing adsorbtion system with intermediate product recovery
Inventor: FRITSCHLER ALVIN H
IPC: C01B32/40
Filed: 1985-03-15
Granted: 1988-03-03
Abstract: A pressure swing adsorption process is used to achieve intermediate product recovery by the introduction of a gas displacement step before, simultaneous with or subsequent to pressure equalization between beds of a multi-bed adsorption system. A cocurrent depressurization step is then employed to achieve intermediate product recovery. A portion of said intermediate product or of the more readily adsorbable component recovered from a bed advantageously being employed to provide displacement gas for another bed in the adsorption system.
Patent AU-741931-B2 (AU)
Title: Gene therapy for congestive heart failure
Inventor: HAMMOND H KIRK
IPC: C12N9/88
Filed: 1997-09-05
Granted: 2001-12-13
Abstract: The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase  beta -adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
Patent AU-620940-B2 (AU)
Title: Contraception system and method
Inventor: PASQUALE SAMUEL A
IPC: A61K31/565
Filed: 1989-10-19
Granted: 1992-02-27
Abstract: A method of contraception is disclosed which comprises a two-stage protocol. In the first stage, an estrogenic compound in a first composition is administered daily as the sole contraceptively active substance to a human female from about Day 2 to about Day 7 of her menstrual cycle, where Day 1 is the first day of menses. The second stage of the protocol occurs immediately thereafter during which at least one follow-up composition containing a progestin is administered daily to the same human female. The follow-up composition can contain a progestin as the sole contraceptively active ingredient, or can contain a combination of an estrogenic compound with a progestin in different weight ratios. A drug delivery system containing daily dosage units is also described.
Patent AU-714710-B2 (AU)
Title: Tricyclic retinoids, methods for their production and use
Inventor: HWANG CHAN KOU
IPC: C07D221/08
Filed: 1995-12-21
Granted: 2000-01-06
Abstract: Tricyclic retinoids having activity for retinoic acid receptors and/or retinoid X receptors are provided. Also provided are pharmaceutical compositions incorporating such tricyclic retinoid compounds and methods for their therapeutic use.
Patent AU-749697-B2 (AU)
Title: Medicinal aerosol formulations
Inventor: KELLER MANFRED
IPC: A61K31/439
Filed: 1999-08-02
Granted: 2002-07-04
Abstract: The use of solid, pharmaceutically acceptable salts of cromoglycic acid and/or nedocromil as carriers in a therapeutically and prophylactically inefficacious amount in suspension aerosol formulations of pharmaceutical active compounds improves the dispersion properties, increases the chemical and physical stability of moisture-sensitive active compounds, makes possible a more accurate dosage, in particular even of low-dose active compounds, and as a rule permits the abandonment of surface-active agents.
Patent AU-663233-B2 (AU)
Title: Optically active 1-phenylpyrrolidone derivative, intermediate for producing the same, and process for producing both
Inventor: YANO SHINGO
IPC: C07D207/26
Filed: 1993-09-08
Granted: 1995-09-28
Abstract: An optically active form of a compound represented by the following formula (II) below is useful as an agent for treating hyperlipidemia which has an activity to inhibit the synthesis of fatty acids and an activity to inhibit the synthesis of cholesterol <CHEM> wherein R' is a hydrogen atom or a lower alkyl group such as an alkyl group having 1 to 6 carbon atoms, and a synthesis method for same is described.